A case of acute myeloid leukemia-M2 with trisomy 4 in addition to t(8;21).

dc.contributor.authorTrivedi, P J
dc.contributor.authorPatel, P S
dc.contributor.authorBrahmbhatt, M M
dc.contributor.authorPatel, B P
dc.contributor.authorGajjar, S B
dc.contributor.authorIyer, R R
dc.contributor.authorParikh, E H
dc.contributor.authorShukla, S N
dc.contributor.authorShah, P M
dc.contributor.authorBakshi, S R
dc.date.accessioned2012-06-05T10:26:44Z
dc.date.available2012-06-05T10:26:44Z
dc.date.issued2008-01
dc.description.abstractt(8;21)(q22;q22) is the most frequently observed karyotypic abnormality associated with acute myeloid leukemia (AML), specifically in FAB-M2. Short-term unstimulated bone marrow (BM) and peripheral blood lymphocyte culture showed 47,XX, +4,t(8;21) in all metaphase plates; and interphase and metaphase results of AML-ETO fusion was positive and trisomy of 4 was confirmed with WCP probes. Trisomy 4 in AML with t(8;21) is a rare numerical abnormality. Here we present such case of patient which may constitute a distinctive subtype.en_US
dc.identifier.citationTrivedi P J, Patel P S, Brahmbhatt M M, Patel B P, Gajjar S B, Iyer R R, Parikh E H, Shukla S N, Shah P M, Bakshi S R. A case of acute myeloid leukemia-M2 with trisomy 4 in addition to t(8;21). Indian Journal of Human Genetics. 2008 Jan; 14(1): 20-22.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/138845
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840780/en_US
dc.subjectAcute myeloid leukemiaen_US
dc.subjectcytogeneticsen_US
dc.subjectfluorescence in situ hybridizationen_US
dc.titleA case of acute myeloid leukemia-M2 with trisomy 4 in addition to t(8;21).en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijhg2008v14n1p20.pdf
Size:
137.3 KB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: